GlassScriptPhysician profile
David Gilbert Mohr
NPI 1427407360
$1,674.99
in general payments reported to CMS, 2019-2025
15 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.99 · 2021: $123 · 2022: $347 · 2023: $274 · 2024: $378 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.59 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $464.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $310.63 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Silk Road Medical, INC. | $165.21 | 2022 | |
| Astellas Pharma US INC | $149.25 | 2023-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $144.66 | 2022-2024 | Airsupra |
| Exact Sciences Corporation | $118.68 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novartis Pharmaceuticals Corporation | $85.74 | 2025 | |
| Pfizer INC. | $71.05 | 2024-2025 | |
| Relievant Medsystems, INC. | $56.84 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.44 | 2023 | Jardiance, Synjardy |
| Abbott Laboratories | $19.10 | 2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $16.09 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Vericel Corporation | $14.30 | 2019 | |
| Nalu Medical, INC. | $13.92 | 2025 | Nalu Neurostimulation System |
| Cranial Technologies, INC | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mohr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.